The future in biotechnology. . .
starts here.
|
IFN-TAU AS A THERAPY FOR AN ANIMAL MODEL OF MULTIPLE SCLEROSIS
:
Multiple sclerosis (MS) is a primary inflammatory demyelinating disease of the central nervous system (CNS) which affects approximately 1/2000 of the US population.In the mouse model for MS, IFN-tau treated mice developed improved clinical scores of demyelination and regained co-ordination. |